[HTML][HTML] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein… - Trends in molecular …, 2023 - cell.com
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
[HTML][HTML] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein… - Trends in Molecular …, 2023 - ncbi.nlm.nih.gov
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein… - Trends in Molecular …, 2023 - research.ed.ac.uk
Existing licensed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …
[HTML][HTML] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein… - Trends in Molecular …, 2023 - Elsevier
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
[HTML][HTML] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein… - Trends in Molecular …, 2023 - cell.com
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines.
R Fraser, A Orta-Resendiz, A MAZEIN… - Trends in Molecular …, 2023 - orbilu.uni.lu
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
[PDF][PDF] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein, DH Dockrell - 2023 - pure.ed.ac.uk
Existing licensed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines.
R Fraser, A Orta-Resendiz, A Mazein… - Trends in Molecular …, 2023 - europepmc.org
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz… - Trends in molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …
[PDF][PDF] Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
R Fraser, A Orta-Resendiz, A Mazein, DH Dockrell - 2023 - pure.ed.ac.uk
Existing licensed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …
include mRNA vaccines by Moderna (mRNA-1273 and the more recent bivalent Wuhan …